We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+12.1%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$4.2B
AUM Growth
+$4.2B
Cap. Flow
+$540M
Cap. Flow %
12.85%
Top 10 Hldgs %
18.08%
Holding
299
New
56
Increased
119
Reduced
60
Closed
32

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$49.4M
2
V icon
Visa
V
+$40.6M
3
ABBV icon
AbbVie
ABBV
+$26.7M
4
AON icon
Aon
AON
+$23.6M
5
C icon
Citigroup
C
+$19.9M

Top Sells

Rank Stock Value
1
MA icon
Mastercard
MA
+$27.6M
2
CSCO icon
Cisco
CSCO
+$15.5M
3
MCK icon
McKesson
MCK
+$11.4M
4
MU icon
Micron Technology
MU
+$10.7M
5
FLS icon
Flowserve
FLS
+$10.1M

Sector Composition

Rank Sector Weight
1 Technology 24.38%
2 Financials 22.67%
3 Healthcare 20.31%
4 Communication Services 9.26%
5 Consumer Discretionary 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TIBX
151
DELISTED
TIBCO SOFTWARE INC
TIBX
$10.2M 0.24%
452,084
+76,800
+20% +$1.88M
CALD
152
DELISTED
Callidus Software, Inc.
CALD
$9.65M 0.23%
+703,267
New +$7.7M
BX icon
153
Blackstone
BX
$106B
$9.54M 0.23%
308,823
+20,236
+7% +$552K
VIV icon
154
Telefônica Brasil
VIV
$22.5B
$9.51M 0.23%
495,000
+218,000
+79% +$4.43M
AMAT icon
155
Applied Materials
AMAT
$410B
$9.46M 0.23%
535,335
-64,800
-11% -$1.13M
IBB icon
156
iShares Biotechnology ETF
IBB
$9.44B
$9.33M 0.22%
123,450
-7,200
-6% -$511K
ALLT icon
157
Allot
ALLT
$373M
$9.29M 0.22%
613,632
+246,937
+67% +$3.35M
XLNX
158
DELISTED
Xilinx Inc
XLNX
$9.29M 0.22%
202,211
-134,250
-40% -$6.04M
VR
159
DELISTED
Validus Hold Ltd
VR
$9.27M 0.22%
230,000
+55,000
+31% +$2.15M
JNPR
160
DELISTED
Juniper Networks
JNPR
$9.18M 0.22%
406,677
-175,000
-30% -$3.55M
GIMO
161
DELISTED
Gigamon Inc.
GIMO
$9.18M 0.22%
+326,847
New +$10.1M
JNJ icon
162
Johnson & Johnson
JNJ
$641B
$9.16M 0.22%
100,000
– –
DWRE
163
DELISTED
DEMANDWARE INC COM STK (DE)
DWRE
$9.06M 0.22%
+141,300
New +$7.88M
ESPR
164
DELISTED
Esperion Therapeutics
ESPR
$8.77M 0.21%
638,175
+58,175
+10% +$847K
QLYS icon
165
Qualys
QLYS
$4.75B
$8.59M 0.2%
+371,950
New +$8.27M
IDTI
166
DELISTED
Integrated Device Technology I
IDTI
$8.57M 0.2%
841,786
-228,658
-21% -$2.28M
RLI icon
167
RLI Corp
RLI
$5.88B
$8.52M 0.2%
350,000
– –
BMY icon
168
Bristol-Myers Squibb
BMY
$128B
$8.5M 0.2%
160,000
– –
SINA
169
DELISTED
Sina Corp
SINA
$8.45M 0.2%
100,250
+9,650
+11% +$789K
KLAC icon
170
KLA
KLAC
$266B
$8.26M 0.2%
1,281,500
-64,000
-5% -$404K
CAVM
171
DELISTED
Cavium, Inc.
CAVM
$7.86M 0.19%
227,950
-55,800
-20% -$2.09M
LNKD
172
DELISTED
LinkedIn Corporation
LNKD
$7.64M 0.18%
35,243
-19,257
-35% -$4.38M
HSTO
173
DELISTED
Histogen Inc. Common Stock
HSTO
$7.54M 0.18%
5,867
+852
+17% +$1.36M
CTSH icon
174
Cognizant
CTSH
$22.3B
$7.41M 0.18%
146,822
+63,000
+75% +$2.87M
RNR icon
175
RenaissanceRe
RNR
$13.7B
$7.3M 0.17%
75,000
– –
5 6
7
8 9

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q4 2013 Portfolio in Review

As of Q4 2013, Polar Capital held 299 positions worth $4.2B, up 112,182% from $3.74M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Polar Capital deployed $540M of net new capital in Q4 2013, opening 56 new positions and adding to 119 existing holdings. Its largest new stake was Pediatrix Medical: 330,000 shares worth $17.6M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Mastercard, an estimated $27.6M trimmed.

  • Polar Capital's largest Q4 2013 buy was Pediatrix Medical: 330,000 shares worth $17.6M.
  • Polar Capital added most to Apple in Q4 2013, an estimated $49.4M increase.
  • Polar Capital's biggest Q4 2013 reduction was Mastercard, cutting an estimated $27.6M.
  • Polar Capital fully exited Brunswick in Q4 2013, selling an estimated $18.3K.
  • Polar Capital's ten largest holdings make up 18% of its $4.2B portfolio in Q4 2013.
  • Polar Capital opened 56 new positions and closed 32 in Q4 2013.
  • Polar Capital's portfolio value rose 112,182% quarter-over-quarter to $4.2B.

Based on Polar Capital's 13F filing for Q4 2013, filed 11 Feb 2014.